Have Norwegians tried psilocybin, and do they accept it as a medicine?
Journal of Psychedelic Studies April 16, 2021 Henrik Børsting Jacobsen, Audun Stubhaug, Bjørn Holmøy et al. 10 citations
Abstract Background Psilocybin is emerging as a promising therapeutic agent for a wide range of psychiatric conditions, and clinical trials on psilocybin-assisted treatment are forthcoming in Scandinavian countries. However, little is known about attitudes towards this psychedelic compound among the general public in Nordic countries. This might represent a confound, and reduce the validity of...
DOI: 10.1556/2054.2021.00167 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Context archaeology
Norwegian
Hallucinogen
+2